Sedative response to pentaerythritol chloral; clinical evaluation of a new chloral derivative in 164 cases.
D001007:Anxiety / Q000628:therapy*; D001008:Anxiety Disorders; D002697:Chloral Hydrate / Q000031:analogs & derivatives; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D011409:Propylene Glycols; D012893:Sleep Wake Disorders / Q000628:therapy*
D006993:Hypnotics and Sedatives; D011409:Propylene Glycols; D002697:Chloral Hydrate; C021100:trichloroacetaldehyde; C008783:pentaerythritol
ANXIETY/therapy; HYPNOTICS AND SEDATIVES/therapeutic use; SLEEP DISORDERS/therapy